News Releases

SonoMotion completed enrollment in the SOUND Break Wave™ pivotal clinical trial.

SonoMotion secures a $2.2M Fastrack NIH SBIR grant to fund future Break Wave™ milestones.

SonoMotion announces FDA de-novo clearance of it’s Stone Clear™ device

Break Wave™ First-in-Human Multicenter Clinical Trial publication selected as the cover article of the Journal of Urology, October 2024 issue. (Article PDF, Journal of Urology Press Release, Infographic Result Summary PPT Download)

Ultrasound propulsion reduces relapse rate incidence by 70% in patients with post-lithotripsy residual fragments as shown in the University of Washington randomized controlled trial published in Journal of Urology (Article PDF, Urology Times Interview)

Best Endourology/Stone Paper – University of Washington’s “Randomized Controlled Trial of Ultrasonic Propulsion–Facilitated Clearance of Residual Kidney Stone Fragments vs Observation” highlighted as the best paper in Stone Disease at the World Congress of Endourology 2024 conference.

Come visit the SonoMotion booth at the American Urological Association conference in San Antonio, TX on May 3-5, 2024 (Booth #1222).